BuzzSparks.org

Celladon


Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and...

Founded in 2000
Homepage:
Total money raised: $129M

92037 2223 Avenida de la Playa
Suite 300

La Jolla
USA CA

Phone: 858-366-4288

Updated on Jan 22, 2014
Celladon at CrunchBase
Krisztina M. Zsebo CEO
Roger Hajjar Co-Founder and Scientific Advisor
Lauren Silverman Board of Directors
Drew Senyei Board of Directors
Past
Tony Evnin Board of Directors

October, 2013

Celladon raised $1.1M in debt_round round

SEC    sec.gov

May, 2012

Celladon raised $10M in unattributed round from MPM Capital

Celladon Raises Additional $10M    finsmes.com

Celladon raised $19.5M in partial round

SEC    sec.gov

February, 2012

Celladon raised $43M in unattributed round from Pfizer Venture Investments, Lundbeckfond Ventures, Novartis Venture Fund, GBS Ventures, Johnson & Johnson Development Corporation, and Venrock

Celladon Closes $43M in Funding    finsmes.com

December, 2011

Celladon raised $500K in debt_round round

SEC    sec.gov

September, 2011

Celladon raised $250K in debt_round round

SEC    sec.gov

July, 2011

Celladon raised $400K in debt_round round

SEC    sec.gov

October, 2010

Celladon raised $2.5M in debt_round round

SEC    sec.gov

November, 2009

Celladon raised $21.8M in a Series C round from Enterprise Partners, Venrock, and Johnson & Johnson Development Corporation

Celladon, Inc.: Series C $21.8M    onbiovc.com

December, 2005

Celladon raised $30M in a Series B round from Kleiner Perkins Caufield & Byers, Domain Associates, Enterprise Partners, and Venrock

Celladon Secures $30 Million in Series B Financing.    thefreelibrary.com

2000

Celladon was founded in 2000